A 16-year-old male patient was admitted to our hospital in March 2012 with chief complaints of systemic lymphadenopathy for >4 years with significant enlargement in the bilateral supraclavicular ...
Janssen’s Sylvant this week became the first drug approved in Europe to treat the rare blood disorder multicentric Castleman’s disease (MCD). The condition causes white blood cells to over-produce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback